Contego Medical
Integrated embolic protection and thrombectomy devices for vascular procedures.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Carotid and peripheral vascular devices
- Product type
- Device
- Headquarters
- Raleigh, NC, United States
- Region
- North America
What they do
Contego Medical develops carotid and peripheral vascular devices, including Neuroguard IEP and Excipio. Ravish Sachar, MD, and Jay Yadav, MD, founded the company. On 16 November 2026, Medtronic announced its intent to acquire Contego for $380 million plus potential payments, with closing expected in Medtronic's fiscal third quarter. Neuroguard IEP Direct received FDA PMA approval, with 510(k) clearance for its embolic protection system announced on 10 November. The company reported 0% 30-day stroke in the PERFORMANCE III intention-to-treat population and a 0.69% major adverse event rate; these are study-specific results.
History and progression
How Contego Medical got here, step by step.
16 November 2026
Planned Medtronic acquisition
Medtronic announced a $380 million acquisition agreement plus potential payments, with closing expected in its fiscal third quarter subject to customary conditions.
Recent news
16 November 2026
Contego Medical announcement16 November 2026
Ravish Sachar, Founder and CEO16 November 2026
Jay Yadav, Co-founder16 November 2026
Contego Medical Planned acquisition details
Related companies